Works matching IS 00126667 AND DT 2023 AND VI 83 AND IP 1
Results: 7
Tremelimumab: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 1, p. 93, doi. 10.1007/s40265-022-01827-8
- By:
- Publication type:
- Article
Correction to: Spesolimab: First Approval.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Ozoralizumab: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 1, p. 87, doi. 10.1007/s40265-022-01821-0
- By:
- Publication type:
- Article
TKI Treatment Sequencing in Advanced Gastrointestinal Stromal Tumors.
- Published in:
- Drugs, 2023, v. 83, n. 1, p. 55, doi. 10.1007/s40265-022-01820-1
- By:
- Publication type:
- Article
An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.
- Published in:
- Drugs, 2023, v. 83, n. 1, p. 75, doi. 10.1007/s40265-022-01819-8
- By:
- Publication type:
- Article
Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval.
- Published in:
- Drugs, 2023, v. 83, n. 1, p. 37, doi. 10.1007/s40265-022-01810-3
- By:
- Publication type:
- Article
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
- Published in:
- Drugs, 2023, v. 83, n. 1, p. 1, doi. 10.1007/s40265-022-01803-2
- By:
- Publication type:
- Article